| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.061 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |